Cargando…

Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587

Stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 play a critical role in mobilization and redistribution of immune cells and hematopoietic stem cells (HSCs). We evaluated effects of two CXCR4-targeting agents, peptide antagonist LY2510924 and monoclonal antibody LY2624587, on mobilizing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Sheng-Bin, Van Horn, Robert D., Yin, Tinggui, Brown, Robin M., Roell, William C., Obungu, Victor H., Ruegg, Charles, Wroblewski, Victor J., Raddad, Eyas, Stille, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706900/ https://www.ncbi.nlm.nih.gov/pubmed/29212254 http://dx.doi.org/10.18632/oncotarget.21816

Ejemplares similares

Population Pharmacokinetic and Pharmacodynamic Modeling of LY2510924 in Patients With Advanced Cancer
por: Bihorel, S, et al.
Publicado: (2017)

Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies
por: Peng, Sheng-Bin, et al.
Publicado: (2016)

Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors
por: O'Hara, Mark H., et al.
Publicado: (2020)

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
por: Boddu, Prajwal, et al.
Publicado: (2018)

Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
Publicado: (2015)

C-terminal–modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4
por: Suzuki, Kentaro, et al.
Publicado: (2019)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
por: Monteith, David, et al.
Publicado: (2017)

LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase
por: Sloan-Lancaster, Joanne, et al.
Publicado: (2017)

Role of Ly-6 in lymphocyte activation. II. Induction of T cell activation by monoclonal anti-Ly-6 antibodies
Publicado: (1986)

Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
por: Li, Yiwen, et al.
Publicado: (2018)

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
por: Luo, Linlin, et al.
Publicado: (2016)

Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
por: Li, Yiwen, et al.
Publicado: (2018)

Differentiation of human subcutaneous adipocytes and measurement of lipolytic function induced by GIP or LY3437943
por: Regmi, Ajit, et al.
Publicado: (2023)

Developmental and communicative interrelations of Ly123 and Ly1 cell sets
Publicado: (1980)

Neces-SARI-ly?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2016)

Running Mad-ly into mitosis
por: LeBrasseur, Nicole
Publicado: (2004)

Virulence profile: Hinh Ly
por: Ly, Hinh
Publicado: (2016)

Comparison of Mouse Ly5(a) and Ly5(b) Leucocyte Common Antigen Alleles
por: Zebedee, Suzanne L., et al.
Publicado: (1991)

Secretion of Ia antigens by a subpopulation of T cells which are Ly-1+, Ly-2-, and Ia-
Publicado: (1976)

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021)

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021)

LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
por: Adams, Andrew C., et al.
Publicado: (2013)

Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors
Publicado: (1978)

Occurrences and Functions of Ly6C(hi) and Ly6C(lo) Macrophages in Health and Disease
por: Li, Yuan-hui, et al.
Publicado: (2022)

Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33
por: Okragly, Angela J, et al.
Publicado: (2021)

Models of Ly$\alpha$ forest clouds
por: Charlton, J C
Publicado: (1995)

Crystal Structure of the FGFR4/LY2874455 Complex Reveals Insights into the Pan-FGFR Selectivity of LY2874455
por: Wu, Daichao, et al.
Publicado: (2016)

Splenic Ly6G(high) mature and Ly6G(int) immature neutrophils contribute to eradication of S. pneumoniae
por: Deniset, Justin F., et al.
Publicado: (2017)

MSCs Contribute to the Conversion of Ly6C(high) Monocytes into Ly6C(low) Subsets under AMI
por: Lu, Wenbin, et al.
Publicado: (2020)

Preclinical findings predicting efficacy and side‐effect profile of LY2940094, an antagonist of nociceptin receptors
por: Witkin, Jeffrey M., et al.
Publicado: (2016)

LncRNA lncLy6C induced by microbiota metabolite butyrate promotes differentiation of Ly6C(high) to Ly6C(int/neg) macrophages through lncLy6C/C/EBPβ/Nr4A1 axis
por: Gao, Yunhuan, et al.
Publicado: (2020)

Ly phenotype of cytotoxic T cells for syngeneic tumor
Publicado: (1976)

Cell size control is sirtuin(ly) exciting
por: Wright, Jill, et al.
Publicado: (2013)

Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes
por: Sloan-Lancaster, Joanne, et al.
Publicado: (2013)

Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
por: Kharitonenkov, Alexei, et al.
Publicado: (2013)

Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses
Publicado: (1976)

Mechanisms of Ly2 suppressor cell activity. Activation of an Ly1 I-J+ cell is required to transduce the suppressive signal
Publicado: (1984)

Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity
Publicado: (1975)

Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms
por: Gutiérrez, José María, et al.
Publicado: (2020)

Conversion of Normal Ly-1-Positive B-Lineage Cells into Ly-1-Positive Macrophages in Long-Term Bone Marrow Cultures
por: Katoh, Shigeki, et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_i2l1scknvslfnqrrvji97r0d4c